Related Experiment Video
Updated: May 1, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Venous thromboembolism in critically ill children
Lee A Polikoff1, E Vincent S Faustino
1Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.
Insights
Venous thromboembolism (VTE) is a growing concern in critically ill children, with limited pediatric-specific guidelines. Further research and risk assessment tools are crucial for early identification and treatment of VTE in this population.
Area of Science:
- Pediatric Critical Care Medicine
- Hematology
- Thrombosis Research
Background:
- Critically ill children face an elevated risk of venous thromboembolism (VTE) due to their underlying conditions and treatments.
- A complex interplay exists between infection and thrombosis, where thrombi can harbor infection and infection elevates VTE risk.
Purpose of the Study:
- To review the current scientific literature concerning venous thromboembolism (VTE) in critically ill pediatric patients.
- To highlight the increasing concern and complications associated with VTE in pediatric critical care settings.
Main Methods:
- Literature review of current studies on VTE in critically ill children.
- Analysis of existing data and guidelines, noting their adult-centric basis.
- Examination of emerging risk assessment tools and novel anticoagulant research.
Main Results:
- Critically ill children are at significant risk for VTE, influenced by medical treatments and underlying diseases.
- Current pediatric VTE guidelines are lacking, relying on adult data; novel anticoagulants are under investigation for pediatric use.
- Development of risk assessment tools and identification of biomarkers are ongoing to predict VTE in this population.
Conclusions:
- Pediatric critical care providers must recognize the significance of VTE for timely diagnosis and management.
- There is a critical need for robust clinical trials to establish evidence-based guidelines for pediatric VTE prevention and treatment.
- Biomarker-integrated risk assessment tools hold promise for improving VTE prediction in critically ill children.
Purpose Of Review:
To review the current literature on venous thromboembolism (VTE) in critically ill children.
Recent Findings:
There is an increasing concern for VTE and its complications in critically ill children. Critically ill children are at increased risk of thromboembolism because of the treatment that they are receiving and their underlying condition. A complex relationship exists between thrombosis and infection. A thrombus is a nidus for infection, while infection increases the risk of thrombosis. Pediatric-specific guidelines for the prevention and treatment of thromboembolism are lacking. Current guidelines are based on the data from adults. Novel anticoagulants are now available for use in adults. Studies are ongoing to determine their safety in children. Risk assessment tools have recently been developed to determine the risk of thromboembolism in critically ill children. Certain molecules are associated with thromboembolism in adults.
Summary:
Pediatric critical care practitioners should be cognizant of the importance of VTE in critically ill children to allow early identification and treatment. Adequately powered clinical trials are critically needed to generate evidence that will guide the treatment and prevention of thromboembolism in critically ill children. Risk assessment tools that incorporate biomarkers may improve our ability to predict the occurrence of thromboembolism in critically ill children.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism I: Introduction
